Abstract

Store-mediated Ca 2+ entry (SMCE), which is rapidly activated by depletion of the intracellular Ca 2+ stores, is a major mechanism for Ca 2+ influx. Several studies have involved tyrosine kinases in the activation of SMCE, such as pp60 src, although at present those involved in the early activation steps are unknown. Here we report the involvement of Bruton's tyrosine kinase (Btk) in the early stages of SMCE in human platelets. Cell treatment with thrombin or thapsigargin (TG) plus ionomycin (Iono) results in rapid activation of Btk, which was independent of rise in intracellular Ca 2+ concentration ([Ca 2+] i) but dependent on H 2O 2 generation. Platelet treatment with Btk inhibitors, LFM-A13 or terreic acid, significantly reduced TG+Iono- and thrombin-evoked SMCE. Btk was rapidly activated by addition of low concentrations of H 2O 2, whose effect on Ca 2+ entry was prevented by Btk inhibitors. Our results indicate that pp60 src and Btk co-immunoprecipitate after platelet stimulation with TG+Iono, thrombin or H 2O 2. In addition, we have found that LFM-A13 impaired actin filament reorganization after store depletion and agonist-induced activation of pp60 src, while the inhibitor of pp60 src, a protein that requires actin reorganization for its activation, did not modify Btk activation, suggesting that Btk is upstream of pp60 src. We propose a role for Btk in the early steps of activation of SMCE in human platelets.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.